Ajax-Loading

Astellas Pharma Inc. - Current Deferred Revenue

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Current-Deferred-Revenue" stands at 36.04 Billion Japanese Yens as of 09/30/2024.'
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -106.63 Billion Japanese Yens compared to the value the year prior.
The 1 year change is -106.63 Billion Japanese Yens.

The Serie's long term average value is -32.96 Billion Japanese Yens. It's latest available value, on 09/30/2024, is 69.00 Billion Japanese Yens higher, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 03/31/2020, to it's latest available value, on 09/30/2024, is +362.04 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 12/31/2023, to it's latest available value, on 09/30/2024, is -113.26 Billion.

Current Deferred Revenue for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Current Deferred Revenue905,699,262,464.00
LogoJohnson & Johnson - Current Deferred Revenue486,508,953,600.00
LogoAbbVie Inc - Current Deferred Revenue399,570,305,024.00
LogoRoche Holding AG - Current Deferred Revenue317,433,206,677.55
LogoAstraZeneca PLC - Current Deferred Revenue280,205,508,085.11